Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Target c-Myc to treat pancreatic cancer
Moein Ala
Cancer Biology & Therapy (2022) Vol. 23, Iss. 1, pp. 34-50
Open Access | Times Cited: 92

Showing 1-25 of 92 citing articles:

Molecular principles underlying aggressive cancers
Ruth Nussinov, Bengi Ruken Yavuz, Hyunbum Jang
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Remodeling tumor microenvironment with natural products to overcome drug resistance
Wanlu Zhang, Shubo Li, Chunting Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 40
The relationship between CD4+ T cell glycolysis and their functions
Siyi Liu, Shan Liao, Liang Lin, et al.
Trends in Endocrinology and Metabolism (2023) Vol. 34, Iss. 6, pp. 345-360
Open Access | Times Cited: 23
Immunotherapy resistance in solid tumors: mechanisms and potential solutions
Daniel S. Lefler, Steven Manobianco, Babar Bashir
Cancer Biology & Therapy (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 14
MYC the oncogene from hell: Novel opportunities for cancer therapy
Adriana Papadimitropoulou, Maria Makri, Grigoris Zoidis
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116194-116194
Closed Access | Times Cited: 11
New insights into protein–protein interaction modulators in drug discovery and therapeutic advance
Hossam Nada, Yongseok Choi, Sung-Do Kim, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 9
Decoding the regulatory roles of non-coding RNAs in cellular metabolism and disease
Yuru Zong, Xuliang Wang, Bing Cui, et al.
Molecular Therapy (2023) Vol. 31, Iss. 6, pp. 1562-1576
Open Access | Times Cited: 22
Beyond cyclopamine: Targeting Hedgehog signaling for cancer intervention
Beena Thazhackavayal Baby, Aniruddha Murahar Kulkarni, Prasanna Kumar Reddy Gayam, et al.
Archives of Biochemistry and Biophysics (2024) Vol. 754, pp. 109952-109952
Open Access | Times Cited: 6
Constructing triazole-modified quinazoline derivatives as selective c-MYC G-quadruplex ligands and potent anticancer agents through click chemistry
Jiong-Heng Cai, Dan-Yan Yang, Junjie Zhang, et al.
Bioorganic Chemistry (2024) Vol. 144, pp. 107173-107173
Closed Access | Times Cited: 5
ZDHHC20-mediated S-palmitoylation of YTHDF3 stabilizes MYC mRNA to promote pancreatic cancer progression
Huan Zhang, Yan Sun, Zhaokai Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
MYC and MET cooperatively drive hepatocellular carcinoma with distinct molecular traits and vulnerabilities
Celia Sequera, Margherita Grattarola, Ágnes Holczbauer, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 11
Open Access | Times Cited: 22
The Functional Role and Regulatory Mechanism of FTO m6A RNA Demethylase in Human Uterine Leiomyosarcoma
Qiwei Yang, Ayman Al‐Hendy
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7957-7957
Open Access | Times Cited: 11
Construction and validation of a RARRES3-based prognostic signature related to the specific immune microenvironment of pancreatic cancer
Yimeng Sun, Xiaoyan Wang, Lin Yao, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
Non-coding RNAs: emerging biomarkers and therapeutic targets in cancer and inflammatory diseases
Basma Hossam Abdelmonem, Lereen T. Kamal, Lilian Waheed Wardy, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Bioinformatics Analysis of Purine Metabolism Key Genes in Gastric Cancer Chemotherapy Resistance and Prognosis
运 邵
Advances in Clinical Medicine (2025) Vol. 15, Iss. 03, pp. 1023-1034
Closed Access
Deciphering of SOX9 Functions in Pancreatic Cancer Cells
К. Н. Кашкин, L. G. Kondratyeva, E. P. Kopantzev, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2652-2652
Open Access
The Structure of Pharmacy Practice in Alabama
Marilyn N. Bulloch, Scott Penzak, Lena McDowell
(2025), pp. 113-124
Closed Access
Legal Requirements Related to the Prescription and Related Items
Marilyn N. Bulloch, Scott Penzak, Lena McDowell
(2025), pp. 159-189
Closed Access
Miscellaneous Laws Impacting Pharmacy Practice in Alabama
Marilyn N. Bulloch, Scott Penzak, Lena McDowell
(2025), pp. 297-312
Closed Access
Laws on Health System and Institutional Pharmacies
Marilyn N. Bulloch, Scott Penzak, Lena McDowell
(2025), pp. 207-227
Closed Access
PUS7 promotes the progression of pancreatic cancer by interacting ANLN to activate MYC pathway
Yubo Jiang, Qian Cheng, Yingying Zhang, et al.
Molecular and Cellular Biochemistry (2025)
Closed Access
Dynamic interaction of MYC enhancer RNA with YEATS2 protein regulates MYC gene transcription in pancreatic cancer
Jayita Roy, Aniket Kumar, Shouvik Chakravarty, et al.
EMBO Reports (2025)
Open Access
α-hederin decreases the glycolysis level in intestinal epithelial cells via SNX10-mediated DEPDC5 degradation
Hui Feng, Jin Wang, Lihuiping Tao, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101301-101301
Open Access
Discovery of Novel SHP2 ATTEC Degraders against Pancreatic Ductal Adenocarcinoma Harboring KRAS(G12D) Mutations
Yue Zhong, Yan Lü, Jiahui Li, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Suppression of Cancer Cell Stemness and Drug Resistance via MYC Destabilization by Deubiquitinase USP45 Inhibition with a Natural Small Molecule
Xiao Tu, Chuncheng Li, Wen Sun, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 930-930
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top